Home > Insider Trading > Filing (0001104659-20-122542)

Filing Details

Accession Number:: 0001104659-20-122542
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-06 16:32:15
Reporting Period:: 2020-08-10

Accepted Time:: 2020-11-06 16:32:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1748907	Orchard Therapeutics Plc	ORTX	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1315082	Ra Capital Healthcare Fund Lp	200 Berkeley Street Boston MA 02116	No	No	Yes	No
1346824	Ra Capital Management, L.p.	200 Berkeley Street, 18Th Floor Boston MA 02116	No	No	Yes	No
1384859	Peter Kolchinsky	C/O Ra Capital Management, L.p. 200 Berkeley Street, 18Th Floor Boston MA 02116	No	No	Yes	No
1619841	M. Rajeev Shah	C/O Ra Capital Management, L.p. 200 Berkeley Street, 18Th Floor Boston MA 02116	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2020-08-10	14,570	$4.75	9,126,418	No	4	P	Indirect	See footnote
Ordinary Shares	Acquisiton	2020-08-10	6,787	$4.71	9,133,205	No	4	P	Indirect	See footnote
Ordinary Shares	Acquisiton	2020-08-12	16,291	$4.74	9,149,496	No	4	P	Indirect	See footnote
Ordinary Shares	Acquisiton	2020-08-14	13,031	$4.74	9,162,527	No	4	P	Indirect	See footnote
Ordinary Shares	Acquisiton	2020-08-17	8,235	$4.74	9,170,762	No	4	P	Indirect	See footnote
Ordinary Shares	Acquisiton	2020-08-18	45,249	$4.72	9,216,011	No	4	P	Indirect	See footnote
Ordinary Shares	Acquisiton	2020-08-19	55,204	$4.69	9,271,215	No	4	P	Indirect	See footnote
Ordinary Shares	Acquisiton	2020-08-19	9,050	$4.65	9,280,265	No	4	P	Indirect	See footnote
Ordinary Shares	Acquisiton	2020-08-20	58,106	$4.61	9,338,371	No	4	P	Indirect	See footnote
Ordinary Shares	Acquisiton	2020-08-20	4,525	$4.61	9,342,896	No	4	P	Indirect	See footnote
Ordinary Shares	Acquisiton	2020-08-21	54,416	$4.64	9,397,312	No	4	P	Indirect	See footnote
Ordinary Shares	Acquisiton	2020-08-21	10,226	$4.51	9,407,538	No	4	P	Indirect	See footnote
Ordinary Shares	Acquisiton	2020-09-24	473,327	$4.61	9,880,865	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Footnotes

RA Capital Management, L.P. (the "Adviser") is the investment manager for the RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The securities reported on this Form 4 are held directly by the Fund. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of such securities, except to the extent of any pecuniary interest therein.
This transaction was executed in multiple trades at prices ranging from $4.72 to $4.71; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.
This transaction was executed in multiple trades at prices ranging from $4.75 to $4.70; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.
This transaction was executed in multiple trades at prices ranging from $4.75 to $4.70; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.
This transaction was executed in multiple trades at prices ranging from $4.70 to $4.65; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.
This transaction was executed in multiple trades at prices ranging from $4.65 to $4.55; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.
This transaction was executed in multiple trades at prices ranging from $4.47 to $4.70; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.
This transaction was executed in multiple trades at prices ranging from $4.50 to $4.52; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.
This transaction was executed in multiple trades at prices ranging from $4.57 to $4.71; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions were effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.